Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Zhejiang Huakang Pharmaceutical Co. Ltd. has 3 pending office actions in the Chemistry & Materials technology area. These 3 actions are distributed across 3 distinct examiners and 3 distinct art units, showing a diverse review process. DRODGE, JOSEPH W is the busiest examiner for the company, currently handling 1 pending action. With 3 distinct examiners each managing 1 of the 3 pending office actions, the workload is spread evenly across the portfolio.
Because each of the 3 distinct examiners is managing 1 of the 3 pending office actions, the portfolio shows no specific examiner concentration beyond the individual level. The involvement of 3 distinct art units further suggests that the Chemistry & Materials filings cover a range of sub-specialties. For practitioners, this means that prosecution strategies may need to be tailored to the specific expectations of different examiners rather than a single point of contact. The presence of 1 pending action for the busiest examiner, DRODGE, JOSEPH W, confirms that no single individual dominates the current pending landscape.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 2 (67%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DRODGE, JOSEPH W | 1 | 78.3% | +38.0% |
| LAU, JONATHAN S | 1 | 63.9% | -17.2% |
| MORENO, LARK JULIA | 1 | 0.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18023836 | SWEETENER LIQUID FOR PREVENTING AND RELIEVING INTESTINAL SUGAR ALCOHOL INTOLERANCE AND PREPARATION METHOD AND APPLICATION THEREOF | MORENO, LARK JULIA | 34d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18655298 | METHOD FOR CRYSTALLIZING COMPOUND SUGAR SOLUTION OF XYLOSE AND SUCROSE | DRODGE, JOSEPH W | — |
| Art Unit | Apps |
|---|---|
| 1773 | 1 |
| 1693 | 1 |
| 1793 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18655298 | METHOD FOR CRYSTALLIZING COMPOUND SUGAR SOLUTION OF XYLOSE AND SUCROSE | DRODGE, JOSEPH W | 1773 | §112Other | Non-Final OA | — | Pending | May 05, 2024 |
| 18651633 | METHODS FOR PREPARING HIGH-PURITY ARABINOSE CRYSTALS | LAU, JONATHAN S | 1693 | §112 | Non-Final OA | — | Pending | Apr 30, 2024 |
| 18023836 | SWEETENER LIQUID FOR PREVENTING AND RELIEVING INTESTINAL SUGAR ALCOHOL INTOLERANCE AND PREPARATION METHOD AND APPLICATION THEREOF | MORENO, LARK JULIA | 1793 | §103§112 | Final Rejection | 34d | Pending | Feb 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialZhejiang Huakang Pharmaceutical Co. Ltd. has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Joseph W Drodge has the most, with 1 of Zhejiang Huakang Pharmaceutical Co. Ltd.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
